These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21284704)

  • 1. Kava, the anxiolytic herb: back to basics to prevent liver injury?
    Teschke R; Sarris J; Glass X; Schulze J
    Br J Clin Pharmacol; 2011 Mar; 71(3):445-8. PubMed ID: 21284704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited.
    Teschke R; Sarris J; Schweitzer I
    Br J Clin Pharmacol; 2012 Feb; 73(2):170-4. PubMed ID: 21801196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kava: herbal panacea or liver poison?
    Moulds RF; Malani J
    Med J Aust; 2003 May; 178(9):451-3. PubMed ID: 12720513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kava hepatotoxicity solution: A six-point plan for new kava standardization.
    Teschke R; Sarris J; Lebot V
    Phytomedicine; 2011 Jan; 18(2-3):96-103. PubMed ID: 21112196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kava hepatotoxicity: pathogenetic aspects and prospective considerations.
    Teschke R
    Liver Int; 2010 Oct; 30(9):1270-9. PubMed ID: 20630022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kava hepatotoxicity--a clinical review.
    Teschke R
    Ann Hepatol; 2010; 9(3):251-65. PubMed ID: 20720265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures.
    Teschke R; Genthner A; Wolff A
    J Ethnopharmacol; 2009 Jun; 123(3):378-84. PubMed ID: 19501269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Review "Kava, kavapyrones and toxic liver injury" by R Teschke, Hanau Zeitschrift für Gastroenterologie 2003, 41:395-404].
    Stickel F; Seitz HK; Schuppan D
    Z Gastroenterol; 2003 Aug; 41(8):888-9. PubMed ID: 12910431
    [No Abstract]   [Full Text] [Related]  

  • 9. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kava hepatotoxicity with Western herbal products: does it occur with traditional kava use?
    Currie BJ; Clough AR
    Med J Aust; 2003 May; 178(9):421-2. PubMed ID: 12720503
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver transplantation and the use of KAVA: Case report.
    Becker MW; Lourençone EMS; De Mello AF; Branco A; Filho EMR; Blatt CR; Mallmann CA; Schneider M; Caregnato RCA; Blatt CR
    Phytomedicine; 2019 Mar; 56():21-26. PubMed ID: 30668342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ethanol in kava hepatotoxicity.
    Li XZ; Ramzan I
    Phytother Res; 2010 Apr; 24(4):475-80. PubMed ID: 19943335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop.
    Thomsen M; Schmidt M
    J Ethnopharmacol; 2021 Mar; 268():113582. PubMed ID: 33189846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
    Sarris J; LaPorte E; Schweitzer I
    Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits.
    Teschke R; Qiu SX; Lebot V
    Dig Liver Dis; 2011 Sep; 43(9):676-81. PubMed ID: 21377431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are kavalactones the hepatotoxic principle of kava extracts? The pitfalls of the glutathione theory.
    Schmidt M
    J Altern Complement Med; 2003 Apr; 9(2):183-7; author reply 187-8. PubMed ID: 12804070
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
    Anke J; Ramzan I
    J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of the safety of kava extract in the treatment of anxiety.
    Stevinson C; Huntley A; Ernst E
    Drug Saf; 2002; 25(4):251-61. PubMed ID: 11994028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kava hepatotoxicity.
    Russmann S; Lauterburg BH; Helbling A
    Ann Intern Med; 2001 Jul; 135(1):68-9. PubMed ID: 11434754
    [No Abstract]   [Full Text] [Related]  

  • 20. Kava extracts: safety and risks including rare hepatotoxicity.
    Teschke R; Gaus W; Loew D
    Phytomedicine; 2003; 10(5):440-6. PubMed ID: 12834011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.